Assignee
CELLID CO LTD
KR·1 granted patent·3 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0162US2026091112A1Vaccine comprising peripheral blood mononuclear cells loaded with natural killer t cell ligand and antigenCELLID CO LTD·Filed 2023·Application pending·0 cites
- 0257US2025170179A1Vaccine comprising natural killer cells loaded with ligands of natural killer t cells and cancer antigensCELLID CO LTD·Filed 2023·Application pending·0 cites
- 0349US12098384B2Adenoviral vector not including replication competent adenovirus, and use thereofCELLID CO LTD·Filed 2022·Granted Sep 24, 2024·0 cites·14 claims
- 0437US2023293670A1Novel coronavirus recombinant spike protein, polynucleotide encoding same, vector comprising polynucleotide, and vaccine for preventing or treating coronavirus infection, comprising vectorCELLID CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLID CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →